Patents-Review.com
🔗 Permalink
Assignee profile:

Eirgen Pharma Ltd.

City:

Waterford

Country:

Ireland

Published Applications:

17

Last publication date:

2023-03-30

Patent Grants:

16

Last grant date:

2025-11-25

Top Inventors for applications by Eirgen Pharma Ltd.

These are the the leading inventors for applications assigned to Eirgen Pharma Ltd.:

Recent patent applications by Eirgen Pharma Ltd.

Eirgen Pharma Ltd. based in Waterford, IE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-03-30
US20230096602A1
Human necessities

TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR TREATMENT OF RENAL DISEASE

 #2 | 2022-04-28 ✅ Patent 12,478,631 granted on 2025-11-25
US20220125806A1
Human necessities

STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME

 #3 | 2022-03-03 ✅ Patent 12,208,106 granted on 2025-01-28
US20220062304A1
Human necessities

Methods of vitamin D treatment

 #4 | 2022-01-06 ✅ Patent 12,133,917 granted on 2024-11-05
US20220000783A1
Human necessities

Pediatric dosage forms, methods of making and using

 #5 | 2021-12-30 ✅ Patent 12,433,842 granted on 2025-10-07
US20210401752A1
Human necessities

PEDIATRIC DOSAGE FORMS, METHODS OF MAKING AND USING

 #6 | 2021-08-26 ✅ Patent 11,738,033 granted on 2023-08-29
US20210260079A1
Human necessities

Adjunctive therapy with 25-hydroxyvitamin D and articles therefor

 #7 | 2020-10-29 ✅ Patent 11,000,480 granted on 2021-05-11
US20200338006A1
Human necessities

Pediatric dosage forms, methods of making and using

 #8 | 2020-08-20 ✅ Patent 12,441,776 granted on 2025-10-14
US20200262887A1
Chemistry; metallurgy

OXYNTOMODULIN PEPTIDE ANALOG FORMULATIONS

 #9 | 2020-08-13 ✅ Patent 11,452,734 granted on 2022-09-27
US20200253987A1
Human necessities

Method of treating and preventing secondary hyperparathyroidism

 #10 | 2020-04-02 ✅ Patent 11,007,205 granted on 2021-05-18
US20200101089A1
Human necessities

Adjunctive therapy with 25-hydroxyvitamin D and articles therefor

 #11 | 2019-12-12 ✅ Patent 11,253,528 granted on 2022-02-22
US20190374555A1
Human necessities

Stabilized modified release Vitamin D formulation and method of administering same

 #12 | 2019-10-03 ✅ Patent 11,590,148 granted on 2023-02-28
US20190298744A1
Human necessities

Use of calcifediol in bariatric surgery patients

 #13 | 2019-03-21 ✅ Patent 11,173,168 granted on 2021-11-16
US20190083513A1
Human necessities

Methods of treating vitamin D insufficiency in chronic kidney disease

 #14 | 2018-02-01 ✅ Patent 11,154,509 granted on 2021-10-26
US20180028453A1
Human necessities

Methods for controlled release oral dosage of a vitamin D compound

 #15 | 2014-04-24 ✅ Patent 11,926,583 granted on 2024-03-12
US20140113886A1
Chemistry; metallurgy

Stabilized 1, 25-dihydroxyvitamin D2 and method of making same

 #16 | 2013-05-30 ✅ Patent 11,672,809 granted on 2023-06-13
US20130137663A1
Human necessities

Methods and compositions for reducing parathyroid levels

 #17 | 2010-05-13 ✅ Patent 11,752,158 granted on 2023-09-12
US20100120728A1
Human necessities

Method of treating vitamin D insufficiency and deficiency

Also check out EIRGEN PHARMA LTD.'s (Waterford, Ireland) applicant profile with 9 patent applications submitted.

AssigneeID:

335466 ⎘